Growing evidence indicates a significant elevation of inflammatory molecules in the brain, cerebrospinal fluid, and peripheral blood of AD patients, including IL-1β, IL-6, IL-10, and TNF-α, among others. The gene discussed is IL10; the disease is Alzheimer disease.